Merit Medical Systems Cash Flow from Financial Activities 2010-2025 | MMSI
Merit Medical Systems annual/quarterly cash flow from financial activities history and growth rate from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Merit Medical Systems cash flow from financial activities for the quarter ending March 31, 2025 was $0.007B, a 138.63% decline year-over-year.
- Merit Medical Systems cash flow from financial activities for the twelve months ending March 31, 2025 was $-0.130B, a 116.96% decline year-over-year.
- Merit Medical Systems annual cash flow from financial activities for 2024 was $-0.06B, a 110.73% decline from 2023.
- Merit Medical Systems annual cash flow from financial activities for 2023 was $0.559B, a 1028.09% decline from 2022.
- Merit Medical Systems annual cash flow from financial activities for 2022 was $-0.06B, a 38.78% decline from 2021.
Merit Medical Systems Annual Cash Flow Financial
(Millions of US $) |
| 2024 |
$-60 |
| 2023 |
$559 |
| 2022 |
$-60 |
| 2021 |
$-98 |
| 2020 |
$-96 |
| 2019 |
$34 |
| 2018 |
$328 |
| 2017 |
$97 |
| 2016 |
$121 |
| 2015 |
$-10 |
| 2014 |
$-17 |
| 2013 |
$15 |
| 2012 |
$208 |
| 2011 |
$47 |
| 2010 |
$76 |
| 2009 |
$8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$5.766B |
$1.357B |
|
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|
